ETF进化论 1881.8%！业余投资大佬段永平晒账户收益。。 原创 阅读全文 ...

格隆汇12月26日丨金时科技(002951.SZ)公布，近日，公司收到天翊创业基金收益分配告知函，天翊创 业对部分股权投资项目退出所得本金和产生的收益进行了分配，本次公司收到的本金和收益为 50,671,404.95元，其中本金为17,009,940.50元，投资处置收益为33,661,464.45元。 ...

证券日报网讯12月17日，西部矿业（601168）在互动平台回答投资者提问时表示，碳酸锂稳定在10万元 以上时，公司对锂资源公司的投资收益可为正。 ...

本次交易顺利实施后，将有利于优化公司资产结构，提高资产运营效率，降低管理成本。通过本次交 易，公司和Ball Corporation的全球战略合作关系继续深化;同时，预计交易将产生一定投资收益，对当 期经营业绩存在正面影响。 奥瑞金（002701）(002701.SZ)公告，公司与RexamLimited于2025年8月26日签署股权买卖协议，公司下 属控股子公司Benepack Hong Kong Limited("贝纳香港")拟向Rexam Limited出售其持有的控股子公司 Benepack Belgium N.V.("贝纳比利时")80%股权。 标的公司整体企业价值为1.38亿欧元，对应80%股权的基础对价为1.104亿欧元，最终交易对价将根据交 割日报表的现金、负债及营运资金等指标进行相应调整，预计调整后交易金额约为5000万欧元至6000万 欧元。交易股权转让后，Rexam Limited持股80%股权，贝纳香港持股20%股权，贝纳比利时将不再纳入 公司合并报表范围。 ...

本次交易顺利实施后，将有利于优化公司资产结构，提高资产运营效率，降低管理成本。通过本次交 易，公司和 Ball Corporation 的全球战略合作关系继续深化;同时，预计交易将产生一定投资收益，对当 期经营业绩存在正面影响。 标的公司整体企业价值为1.38亿欧元，对应80%股权的基础对价为1.104亿欧元，最终交易对价将根据交 割日报表的现金、负债及营运资金等指标进行相应调整，预计调整后交易金额约为5000万欧元至6000万 欧元。交易股权转让后，Rexam Limited 持股 80%股权，贝纳香港持股 20%股权，贝纳比利时将不再纳 入公司合并报表范围。 智通财经APP讯，奥瑞金(002701.SZ)公告，公司与RexamLimited于2025年8月26日签署股权买卖协议， 公司下属控股子公司 Benepack Hong Kong Limited("贝纳香港")拟向 Rexam Limited 出售其持有的控股子 公司 Benepack Belgium N.V.("贝纳比利时")80%股权。 ...

新华财经香港12月15日电（记者林迎楠）香港特区政府统计处15日发表2025年第三季度的香港本地居民 总收入及相关数字的初步统计数字显示，第三季度，以当时市价计算的香港本地生产总值估计为8537亿 港元，同比提升4.8%。 数据显示，第三季度，以当时市价计算的香港本地居民总收入（指香港居民通过从事各项经济活动而赚 取的总收入）较上年同期上升1.5%至9082亿港元；本地居民总收入较本地生产总值多出545亿港元，相 当于该季本地生产总值的6.4%，主要是由于投资收益净流入。 此外，第三季度的香港初次收入（主要包括投资收益）总流入为5761亿港元，同比下跌7.4%，相当于 该季本地生产总值的67.5%。与此同时，初次收入总流出也较上年同期下跌3.8%至5215亿港元，相当于 该季本地生产总值的61.1%。 就投资收益流入的主要组成部分而言，直接投资收益同比下跌4.9%，主要是因为部分本地大型企业在 外地的直接投资收益减少。证券投资收益同比下跌10.6%，主要是由于本地投资者获取的非本地股权证 券的股息收益减少。 就投资收益流出的主要组成部分而言，直接投资收益同比下跌4.1%，主要是由于部分大型跨国企业在 本地的直 ...

就投资收益流入的主要组成部分而言，直接投资收益较上年同期下跌4.9%，主要是因为部分本地大型 企业在外地的直接投资收益减少。证券投资收益较上年同期录得10.6%的显著跌幅，主要是由于本地投 资者获取的非本地股权证券的股息收益减少。 智通财经APP获悉，12月15日，香港政府统计处发表2025年第三季的香港本地居民总收入及相关数字的 初步统计数字。2025年第三季以当时市价计算的香港本地居民总收入(指香港居民透过从事各项经济活 动而赚取的总收入)较上年同期上升1.5%至9,082亿港元。同季以当时市价计算的本地生产总值估计为 8,537亿港元，同比升幅为4.8%。2025年第三季的本地居民总收入较本地生产总值多出545亿港元，相当 于该季本地生产总值的6.4%，主要是由于投资收益净流入。 扣除其间价格变动的影响后，2025年第三季的香港本地居民总收入较上年同期实质上升0.2%，而本地 生产总值在同季实质上升3.8%。 2025年第三季的香港初次收入(主要包括投资收益)总流入为5,761亿港元，较上年同期下跌7.4%，相当于 该季本地生产总值的67.5%。与此同时，2025年第三季的初次收入总流出亦较上年同期下跌 ...

Core Viewpoint - China Galaxy Securities (601881) is expected to continue releasing growth potential due to its advantages in risk management, customer base, and policy benefits, amid industry recovery and business structure optimization, with a target price of HKD 12.66 and a "Buy" rating [1] Financial Performance - For the first three quarters of 2025, the company achieved revenue of CNY 22.75 billion, a year-on-year increase of 44.4%, and a net profit attributable to shareholders of CNY 10.97 billion, up 57.5% year-on-year; the weighted average ROE reached 8.77%, an increase of 2.97 percentage points year-on-year [2] - In Q3 alone, the net profit attributable to shareholders was CNY 4.48 billion, soaring 73.9% year-on-year and 29.0% quarter-on-quarter, marking the best single-quarter performance in history [2] Brokerage and Margin Financing - The brokerage business net income reached CNY 6.31 billion, a year-on-year increase of 70.7%, accounting for approximately 28% of total revenue; Q3 revenue was CNY 2.66 billion, up 125% year-on-year and 54% quarter-on-quarter, significantly outpacing market transaction growth [3] - The average daily trading volume of stock funds in the market increased by 113% year-on-year to CNY 1.81 trillion, and the margin financing balance reached CNY 2.39 trillion, a year-on-year increase of 66.2% [3] Investment Performance - The net investment income (including fair value changes) for the first three quarters was CNY 12.103 billion, achieving a year-on-year growth of 42.4%; Q3 alone saw a year-on-year increase of 32.6% [4] - As of the end of Q3, the financial asset scale was CNY 417 billion, a 9% increase from the beginning of the year, with other debt investments increasing by 16.3% to CNY 256.7 billion [4] Investment Banking Recovery - Investment banking net income for the first three quarters was CNY 480 million, a year-on-year increase of 29.9%; equity underwriting scale reached CNY 24.1 billion, a year-on-year increase of 1,420% [5] - The bond underwriting scale was CNY 576.1 billion, a year-on-year increase of 76.1%, with market share rising to 4.7% [5] - The company expects net profits attributable to shareholders for 2025-2027 to be CNY 14.7 billion, CNY 16.9 billion, and CNY 18.3 billion, corresponding to year-on-year growth rates of 46.5%, 14.9%, and 8.6% respectively [5]

Core Viewpoint - Qianjin Pharmaceutical (600479) confirmed that during the transition period of its acquisition plan, any profits or increases in net assets from the target company will be enjoyed by the listed company [1] Group 1 - The company responded to investor inquiries on an interactive platform regarding its acquisition plan [1] - The increase in investment income for the company in the third quarter was attributed to the investment returns from its stake in the Guohai Guochuang Pharmaceutical Fund [1]

Core Viewpoint - JinWind Technology announced a significant reduction in its holdings of Jinli Permanent Magnet shares, which is expected to positively impact its financial performance in 2025 [1] Group 1: Share Reduction Details - From October 13, 2025, to December 5, 2025, JinWind Investment, a wholly-owned subsidiary, reduced its holdings by 12.2848 million shares through centralized bidding and block trading, with a total transaction amount of approximately 459 million yuan [1] - As of December 5, 2025, JinWind Investment holds 25.1508 million shares of Jinli Permanent Magnet, representing 1.83% of the total share capital [1] Group 2: Financial Impact - The company estimates that it will gain an investment income of approximately 215 million yuan (before income tax), which accounts for about 11.53% of the audited net profit attributable to shareholders of the listed company for the fiscal year 2024 [1] - This investment income is expected to have a positive effect on the company's performance in 2025 [1]